Biohacker Network
PeptidesEvidence: Mixed

GHK-Cu: Real Skin Science, Route-Dependent Evidence & the Injectable Question

Written by
Daniel Reyes, PhD
Medically reviewed by
Dr. Sarah Lindqvist, MD
Published
June 20, 2025
Updated
June 20, 2025
Last medical review
June 20, 2025
Reviewer scope
Metabolic health
Dark glass dropper bottle of copper peptide GHK-Cu serum — the topical format with controlled cosmetic evidence behind it

GHK-Cu is a naturally occurring copper-binding tripeptide that declines with age and is genuinely well studied — topically. Small controlled cosmetic trials support improvements in skin density, elasticity, and wrinkle measures from creams and serums. Injectable GHK-Cu is a different proposition with essentially no controlled human evidence, plus copper-load and product-grade questions topical use never raises.

The evidence that exists

Placebo-controlled cosmetic studies of GHK-Cu creams reported measurable improvements in skin thickness and wrinkle depth over 8–12 weeks. In-vitro gene-expression work shows remodeling-related signaling — the mechanistic backdrop for the cosmetic findings.

Premium skincare flatlay with serum bottles, the evidenced topical route for GHK-Cu skin density and wrinkle improvements

Where the injectable story breaks

  • Controlled human trials of injected GHK-Cu: effectively none
  • Systemic copper delivery raises dose questions topicals avoid
  • Cosmetic-grade raw material is not injection-grade
  • FDA compounding communications have flagged injectable peptide categories broadly

Route-dependent evidence is a recurring theme — BPC-157 oral vs injectable shows the same pattern. The compound-by-compound overview sits in the peptide cheat sheet, stacking claims in the stacks review, and the full profile in our GHK-Cu monograph.

Sensible takeaway

If your interest is skin, the evidenced format is the boring one on a shelf. Anyone pitching systemic injection benefits is extrapolating from petri dishes.

Frequently asked questions

Does GHK-Cu actually work for skin?
Topically, the evidence is real: small placebo-controlled cosmetic studies of GHK-Cu creams reported measurable improvements in skin thickness, elasticity, and wrinkle depth over 8–12 weeks, with supporting in-vitro gene-expression work on remodeling pathways.
Is injectable GHK-Cu safe or effective?
Injectable GHK-Cu has essentially no controlled human evidence and raises questions topical use never does: systemic copper load, injection-grade purity versus cosmetic-grade raw material, and FDA compounding concerns around injectable peptides broadly.
Is GHK-Cu FDA-approved?
Topical cosmetic use is common and regulated as cosmetics are; the injectable form is not an approved drug. If your interest is skin, the evidenced format is the topical one on a shelf.

Questions to ask a licensed clinician

  • Does topical evidence cover what I actually want?
  • Any copper-metabolism history (e.g., Wilson’s) that changes risk?

References

  1. Pickart L, Margolina A (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. SourceReview
  2. US Food and Drug Administration (2023). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA Human Drug Compounding. SourceAgency notice

Related tools

Related guides

Something incorrect in this guide? Report a correction. Material corrections are noted on the page with the date and nature of the change.